2m 2m 2m 2m 2m 2m 2m
TANGO THERAPETCS (TNGX)
NASDAQ
$28.41+$0.05 (+0.16%)
Price as of Jul 14, 2026 4:01 AM EDT- $5.1BMarket Cap
- 365.68%1-Year Change
- BiotechnologyIndustry
TANGO THERAPETCS (TNGX)
$28.41+$0.05 (+0.16%)
TNGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $28.36 | ||
Change | -$2.70 (-8.69%) | ||
Open | $30.55 | ||
High | $30.77 | ||
Low | $28.25 | ||
Previous Close | $31.06 | ||
Volume | 2,504,808 | ||
30-Day Average Volume | 4,868,555 | ||
1-Week Change | -5.28% | ||
1-Month Change | -8.34% | ||
1-Year Change | 365.68% | ||
3-Year Change | 722.03% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 162.8M | ||
Total Assets | $435.8M | ||
Market Cap | $5.1B | ||
Enterprise Value | $4.9B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$45.5M | ||
Free Cash Flow | -$44.4M | ||
EBIT | -$45.5M | ||
EBITDA | -$45.0M | ||
Net Working Capital | $378.0M | ||
EPS | -$0.32 | ||
Enterprise Value/EBITDA | -109 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 13 | ||
P/E | -97 | ||
PEG | 25 | ||
Price/Free Cash Flow | -114 | ||
Price/Operating Cash Flow | -114 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue